Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 38, Issue 12 (Dec 2000)

Issues

Erythrocyte Superoxide Dismutase and Glutathione Peroxidase Activities, and Malondialdehyde and Reduced Glutathione Levels in Schizophrenic Patients

Irfan Altuntas / Hülya Aksoy / Irfan Coskun / Ali Çayköylü / Fatih Akçay
Published Online: 2005-07-05 | DOI: https://doi.org/10.1515/CCLM.2000.201

Abstract

There is abundant evidence that free radicals are involved in membrane pathology in the central nervous system and that they may play a role in neuropsychiatric disorders, including schizophrenia. In this study, we investigated erythrocyte superoxide dismutase and glutathione peroxidase activities as antioxidant enzymes, malondialdehydes as a sign of lipid peroxidation, and reduced glutathione levels in schizophrenic patients. Activities of superoxide dismutase and levels of malondialdehyde in erythrocytes were greater in all patients (n=48) and in patients with acute (n=16) and chronic schizophrenia (n=32) (p<0.001 for all patients and chronic patient group; p<0.05 for acute patient group). The activities of glutathione peroxidase were lower in patients (p<0.05 for all patients and acute patient group; p=0.051 for chronic patient group) compared with the control group. Mean erythrocyte reduced glutathione was lower in patients than in controls (p<0.05). In the patient group, erythrocyte superoxide dismutase activity was positively correlated with scales and duration of disease and erythrocyte malondialdehyde concentration. These data reveal that antioxidative defense mechanisms might be impaired in schizophrenic patients.

About the article

Published Online: 2005-07-05

Published in Print: 2000-12-04


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2000.201.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[2]
L G Nucifora, T Tanaka, L N Hayes, M Kim, B J Lee, T Matsuda, F C Nucifora Jr, T Sedlak, R Mojtabai, W Eaton, and A Sawa
Translational Psychiatry, 2017, Volume 7, Number 8, Page e1215
[3]
D A Maas, A Vallès, and G J M Martens
Translational Psychiatry, 2017, Volume 7, Number 7, Page e1171
[4]
The-Vinh Tran, Eun-Joo Shin, Lan Thuy Ty Nguyen, Youngho Lee, Dae-Joong Kim, Ji Hoon Jeong, Choon-Gon Jang, Seung-Yeol Nah, Kazuya Toriumi, Toshitaka Nabeshima, Kiyofumi Yamada, and Hyoung-Chun Kim
Molecular Neurobiology, 2017
[5]
S Lavoie, M Berger, M Schlögelhofer, M R Schäfer, S Rice, S-W Kim, J Hesse, P D McGorry, S Smesny, and G P Amminger
Translational Psychiatry, 2017, Volume 7, Number 3, Page e1064
[6]
Li Tian, Chin Wai Hui, Kanchan Bisht, Yunlong Tan, Kaushik Sharma, Song Chen, Xiangyang Zhang, and Marie-Eve Tremblay
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2017, Volume 79, Page 27
[7]
S. Salim
Journal of Pharmacology and Experimental Therapeutics, 2016, Volume 360, Number 1, Page 201
[8]
Vittorio Calabrese, James Giordano, Rosalia Crupi, Rosanna Di Paola, Martino Ruggieri, Rio Bianchini, Maria Laura Ontario, Salvatore Cuzzocrea, and Edward J. Calabrese
Journal of Neuroscience Research, 2017, Volume 95, Number 5, Page 1182
[9]
[10]
Alessandro Minarini, Silvia Ferrari, Martina Galletti, Nina Giambalvo, Daniela Perrone, Giulia Rioli, and Gian Maria Galeazzi
Expert Opinion on Drug Metabolism & Toxicology, 2017, Volume 13, Number 3, Page 279
[11]
The-Vinh Tran, Eun-Joo Shin, Ji Hoon Jeong, Ji Won Lee, Youngho Lee, Choon-Gon Jang, Seung-Yeol Nah, Xin Gen Lei, Kazuya Toriumi, Kiyofumi Yamada, Toshitaka Nabeshima, and Hyoung-Chun Kim
Molecular Neurobiology, 2016
[12]
The-Vinh Tran, Eun-Joo Shin, Sung Kwon Ko, Yunsung Nam, Yoon Hee Chung, Ji Hoon Jeong, Choon-Gon Jang, Seung-Yeol Nah, Kiyofumi Yamada, Toshitaka Nabeshima, Jae Kyung Byun, and Hyoung-Chun Kim
Journal of Medicinal Food, 2016, Volume 19, Number 10, Page 961
[13]
Lijing Xin, Ralf Mekle, Margot Fournier, Philipp S. Baumann, Carina Ferrari, Luis Alameda, Raoul Jenni, Huanxiang Lu, Benoit Schaller, Michel Cuenod, Philippe Conus, Rolf Gruetter, and Kim Q. Do
Schizophrenia Bulletin, 2016, Volume 42, Number 5, Page 1185
[14]
Muhammad Ummear Raza, Turan Tufan, Yan Wang, Christopher Hill, and Meng-Yang Zhu
Neurotoxicity Research, 2016, Volume 30, Number 2, Page 251
[15]
Minori Koga, Anthony V. Serritella, Akira Sawa, and Thomas W. Sedlak
Schizophrenia Research, 2016, Volume 176, Number 1, Page 52
[16]
Deepmala, John Slattery, Nihit Kumar, Leanna Delhey, Michael Berk, Olivia Dean, Charles Spielholz, and Richard Frye
Neuroscience & Biobehavioral Reviews, 2015, Volume 55, Page 294
[17]
Kumari Nishi and Swarndeep Singh Hundal
Food and Chemical Toxicology, 2013, Volume 62, Page 732
[18]
Marija Bošković, Iztok Grabnar, Tea Terzič, Blanka Kores Plesničar, and Tomaž Vovk
Psychiatry Research, 2013, Volume 210, Number 3, Page 761
[19]
Shailja Chambial, Shailendra Dwivedi, Kamla Kant Shukla, Placheril J. John, and Praveen Sharma
Indian Journal of Clinical Biochemistry, 2013, Volume 28, Number 4, Page 314
[21]
Joshua Flatow, Peter Buckley, and Brian J. Miller
Biological Psychiatry, 2013, Volume 74, Number 6, Page 400
[22]
Alexander M. Ponizovsky, Gregory Barshtein, and Lev D. Bergelson
Harvard Review of Psychiatry, 2003, Volume 11, Number 6, Page 317
[23]
Jing Qin Wu, Thomas R. Kosten, and Xiang Yang Zhang
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2013, Volume 46, Page 200
[24]
Michael Berk, Gin S. Malhi, Laura J. Gray, and Olivia M. Dean
Trends in Pharmacological Sciences, 2013, Volume 34, Number 3, Page 167
[25]
Čedo Miljević, Aleksandra Nikolić-Kokić, Milan Nikolić, Vesna Niketić, Mihajlo B. Spasić, Dušica Lečić-Toševski, and Duško Blagojević
Human Psychopharmacology: Clinical and Experimental, 2013, Volume 28, Number 1, Page 1
[26]
Chirayu D. Pandya, Kristy R. Howell, and Anilkumar Pillai
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2013, Volume 46, Page 214
[27]
Fátima Ruiz-Litago, Jesús Seco, Enrique Echevarría, Mónica Martínez-Cengotitabengoa, Javier Gil, Jon Irazusta, and Ana María González-Pinto
Psychiatry Research, 2012, Volume 200, Number 2-3, Page 218
[28]
Monia Raffa, Sana Barhoumi, Fatma Atig, Chiraz Fendri, Abdelhamid Kerkeni, and Anwar Mechri
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2012, Volume 39, Number 2, Page 371
[29]
Tihomir Stojković, Nevena V. Radonjić, Milica Velimirović, Gordana Jevtić, Vera Popović, Mirjana Doknić, and Nataša D. Petronijević
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2012, Volume 39, Number 1, Page 192
[30]
Sylvain Grignon and Jean Marc Chianetta
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2007, Volume 31, Number 2, Page 365
[31]
Björn Regland
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2005, Volume 29, Number 7, Page 1124
[32]
H. Serdar Gergerlioglu, Haluk A. Savas, Feridun Bulbul, Salih Selek, Efkan Uz, and Mehmet Yumru
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2007, Volume 31, Number 3, Page 697
[33]
Cedo Miljevic, Milan Nikolic, Aleksandra Nikolic-Kokic, David R. Jones, Vesna Niketic, Dusica Lecic-Tosevski, and Mihajlo B. Spasic
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010, Volume 34, Number 2, Page 303
[34]
Monia Raffa, Anwar Mechri, Leila Ben Othman, Chiraz Fendri, Lotfi Gaha, and Abdelhamid Kerkeni
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2009, Volume 33, Number 7, Page 1178
[35]
Didem Oztop, Hatice Altun, Gülden Baskol, and Saliha Ozsoy
Clinical Biochemistry, 2012, Volume 45, Number 10-11, Page 745
[36]
Jana Kodydková, Lucie Vávrová, Miroslav Zeman, Roman Jirák, Jaroslav Macášek, Barbora Staňková, Eva Tvrzická, and Aleš Žák
Clinical Biochemistry, 2009, Volume 42, Number 13-14, Page 1368
[37]
C. Fendri, A. Mechri, G. Khiari, A. Othman, A. Kerkeni, and L. Gaha
L'Encéphale, 2006, Volume 32, Number 2, Page 244
[38]
Andreas Johannes Schmidt, Ulrich Michael Hemmeter, Jürgen-Christian Krieg, Helmut Vedder, and Philip Heiser
Journal of Psychiatric Research, 2009, Volume 43, Number 8, Page 818
[39]
Čedo Miljević, Aleksandra Nikolić-Kokić, Zorica S. Saičić, Maja Milosavljević, Duško Blagojević, Dušica Lečić Toševski, David R. Jones, and Mihajlo B. Spasić
Psychiatry Research, 2010, Volume 178, Number 1, Page 68
[40]
Monia Raffa, Fatma Atig, Ahmed Mhalla, Abdelhamid Kerkeni, and Anwar Mechri
BMC Psychiatry, 2011, Volume 11, Number 1
[41]
Leila Ben Othmen, Anwar Mechri, Chiraz Fendri, Muriel Bost, Guy Chazot, Lotfi Gaha, and Abdelhamid Kerkeni
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008, Volume 32, Number 1, Page 155
[42]
Michel Bounias and Mark Purdey
Science of The Total Environment, 2002, Volume 297, Number 1-3, Page 1
[43]
S Salih Zoroǧlu, Hasan Herken, Muhittin Yürekli, Efkan Uz, Hamdi Tutkun, Haluk A Savaş, Cahit Baǧci, Murat Eren Özen, Beyhan Cengiz, Ecir Ali Çakmak, M Ilker Doǧru, and Ömer Akyol
Journal of Psychiatric Research, 2002, Volume 36, Number 5, Page 309
[44]
Michael Berk, Felicity Ng, Olivia Dean, Seetal Dodd, and Ashley I. Bush
Trends in Pharmacological Sciences, 2008, Volume 29, Number 7, Page 346
[45]
Wei-Yi Ong, Kang Sim, and Akhlaq A. Farooqui
Asia-Pacific Psychiatry, 2010, Volume 2, Number 4, Page 180
[46]
Jeremy W. Gawryluk, Jun-Feng Wang, Ana C. Andreazza, Li Shao, and L. Trevor Young
The International Journal of Neuropsychopharmacology, 2011, Volume 14, Number 01, Page 123
[47]
Véronique Paban, Florence Fauvelle, and Béatrice Alescio-Lautier
European Journal of Neuroscience, 2010, Volume 31, Number 6, Page 1063
[48]
Seetal Dodd, Olivia Dean, David L Copolov, Gin S Malhi, and Michael Berk
Expert Opinion on Biological Therapy, 2008, Volume 8, Number 12, Page 1955
[49]
Felicity Ng, Michael Berk, Olivia Dean, and Ashley I. Bush
The International Journal of Neuropsychopharmacology, 2008, Volume 11, Number 06
[50]
G. N. Dakhale, S. D. Khanzode, S. S. Khanzode, and A. Saoji
Psychopharmacology, 2005, Volume 182, Number 4, Page 494
[51]
Haluk Asuman Savas, Hasan Serdar Gergerlioglu, Ferah Armutcu, Hasan Herken, H. Ramazan Yilmaz, Esra Kocoglu, Salih Selek, Hamdi Tutkun, Suleyman Salih Zoroglu, and Omer Akyol
The World Journal of Biological Psychiatry, 2006, Volume 7, Number 1, Page 51
[52]
W. Jordan, S. Cohrs, D. Degner, A. Meier, A. Rodenbeck, G. Mayer, J. Pilz, E. Rüther, J. Kornhuber, and S. Bleich
Journal of Neural Transmission, 2006, Volume 113, Number 2, Page 239
[53]
MURAD ATMACA, ERTAN TEZCAN, MURAT KULOGLU, BILAL USTUNDAG, and OZLEM KIRTAS
Psychiatry and Clinical Neurosciences, 2005, Volume 59, Number 6, Page 652

Comments (0)

Please log in or register to comment.
Log in